P. Pouliquen

922 total citations
23 papers, 707 citations indexed

About

P. Pouliquen is a scholar working on Ophthalmology, Public Health, Environmental and Occupational Health and Pharmacology. According to data from OpenAlex, P. Pouliquen has authored 23 papers receiving a total of 707 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Ophthalmology, 10 papers in Public Health, Environmental and Occupational Health and 5 papers in Pharmacology. Recurrent topics in P. Pouliquen's work include Ocular Surface and Contact Lens (9 papers), Glaucoma and retinal disorders (7 papers) and Ocular Infections and Treatments (4 papers). P. Pouliquen is often cited by papers focused on Ocular Surface and Contact Lens (9 papers), Glaucoma and retinal disorders (7 papers) and Ocular Infections and Treatments (4 papers). P. Pouliquen collaborates with scholars based in France, Italy and Belgium. P. Pouliquen's co-authors include Christophe Baudouin, Arnaldo Figueiredo, Thierry Zeyen, Gianluca Manni, Dominique Brémond‐Gignac, P. Goldschmidt, Andrea Leonardi, I. Cochereau, Jean Donadieu and S. Milazzo and has published in prestigious journals such as Clinical Microbiology and Infection, British Journal of Ophthalmology and European Journal of Ophthalmology.

In The Last Decade

P. Pouliquen

20 papers receiving 659 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Pouliquen France 11 500 493 261 77 59 23 707
Mohammad‐Ali Javadi Iran 17 433 0.9× 535 1.1× 584 2.2× 29 0.4× 30 0.5× 62 995
Rookaya Mather Canada 12 180 0.4× 419 0.8× 133 0.5× 44 0.6× 39 0.7× 21 573
Joel M. Dougherty United States 8 310 0.6× 258 0.5× 79 0.3× 31 0.4× 111 1.9× 10 497
Olga Sanabria Colombia 9 484 1.0× 279 0.6× 197 0.8× 104 1.4× 122 2.1× 22 687
Elizabeth Yeu United States 19 434 0.9× 615 1.2× 567 2.2× 72 0.9× 249 4.2× 57 1.1k
Nikhil S Gokhale India 8 150 0.3× 189 0.4× 202 0.8× 23 0.3× 18 0.3× 17 343
J I McGill United States 8 226 0.5× 165 0.3× 77 0.3× 17 0.2× 27 0.5× 8 323
Antonio Elizondo United States 4 279 0.6× 70 0.1× 87 0.3× 88 1.1× 322 5.5× 4 496
Tim Grant Australia 6 407 0.8× 264 0.5× 233 0.9× 33 0.4× 55 0.9× 10 457
Yosai Mori Japan 15 242 0.5× 414 0.8× 465 1.8× 11 0.1× 9 0.2× 79 668

Countries citing papers authored by P. Pouliquen

Since Specialization
Citations

This map shows the geographic impact of P. Pouliquen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Pouliquen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Pouliquen more than expected).

Fields of papers citing papers by P. Pouliquen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Pouliquen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Pouliquen. The network helps show where P. Pouliquen may publish in the future.

Co-authorship network of co-authors of P. Pouliquen

This figure shows the co-authorship network connecting the top 25 collaborators of P. Pouliquen. A scholar is included among the top collaborators of P. Pouliquen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Pouliquen. P. Pouliquen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brémond‐Gignac, Dominique, Jean Donadieu, Andrea Leonardi, et al.. (2008). Prevalence of vernal keratoconjunctivitis: a rare disease?. British Journal of Ophthalmology. 92(8). 1097–1102. 91 indexed citations
2.
Denis, F., C. Chaumeil, P. Goldschmidt, et al.. (2008). Microbiologic Efficacy of 3-day Treatment with Azithromycin 1.5% Eyedrops for Purulent Bacterial Conjunctivitis. European Journal of Ophthalmology. 18(6). 858–868. 14 indexed citations
3.
Chiambaretta, Frédéric, R. Garraffo, P. Pouliquen, et al.. (2008). Tear Concentrations of Azithromycin following Topical Administration of a Single Dose of Azithromycin 0.5%, 1.0%, and 1.5% Eyedrops (T1225) in Healthy Volunteers. European Journal of Ophthalmology. 18(1). 13–20. 19 indexed citations
4.
Leonardi, Andrea, Dominique Brémond‐Gignac, M. Bortolotti, et al.. (2007). Clinical and biological efficacy of preservative-free NAAGA eye-drops versus levocabastine eye-drops in vernal keratoconjunctivitis patients. British Journal of Ophthalmology. 91(12). 1662–1666. 25 indexed citations
5.
Laurichesse, Hélène, F. Gourdon, H. L. Smits, et al.. (2007). Safety and immunogenicity of subcutaneous or intramuscular administration of a monovalent inactivated vaccine against Leptospira interrogans serogroup Icterohaemorrhagiae in healthy volunteers. Clinical Microbiology and Infection. 13(4). 395–403. 24 indexed citations
6.
Pouliquen, P., et al.. (2006). Évaluation de la séroconversion obtenue par vaccination contre la leptospirose humaine. Archives des maladies professionnelles et de médecine du travail/Archives des maladies professionnelles et de l'environnement. 67(3). 536–536.
7.
Cochereau, I., Moncef Khairallah, A. Amraoui, et al.. (2006). 3-day treatment with azithromycin 1.5% eye drops versus 7-day treatment with tobramycin 0.3% for purulent bacterial conjunctivitis: multicentre, randomised and controlled trial in adults and children. British Journal of Ophthalmology. 91(4). 465–469. 39 indexed citations
9.
Viau, Sabrina, et al.. (2006). Amélioration de la symptomatologie chez des patients atteints de sécheresse oculaire et traités oralement par des acides gras polyinsaturés. Journal Français d Ophtalmologie. 29(8). 868–873. 40 indexed citations
10.
Bron, Alain M., et al.. (2004). Comparaison du timolol sans conservateur et du timolol à délivrance prolongée donnés une fois par jour en association à du latanoprost. Journal Français d Ophtalmologie. 27(9). 971–977. 7 indexed citations
11.
Chiambaretta, Frédéric, et al.. (2004). Intérêt d’une nouvelle formulation de diclofénac sans conservateur pour la surface oculaire. Journal Français d Ophtalmologie. 27(7). 739–744. 8 indexed citations
12.
Chiambaretta, F., et al.. (2004). Efficacité et tolérance d’un gel de carbomère fluide versus un gel de carbomère classique lors du traitement du syndrome sec. Journal Français d Ophtalmologie. 27(2). 130–135. 7 indexed citations
13.
Pouliquen, P., et al.. (2001). Evaluation de la tolérance de la vaccination contre Leptospira icterohaemorrhagiae chez 50 employés de canaux. 62(1). 35–40. 3 indexed citations
14.
Pouliquen, P.. (1999). [Carbomer gels in the treatment of dry eye].. PubMed. 22(8). 903–13. 7 indexed citations
15.
Chiambaretta, F., P. Pouliquen, & D. Rigal. (1997). [Allergy and preservatives. Apropos of 3 cases of allergy to benzalkonium chloride].. PubMed. 20(1). 8–16. 8 indexed citations
16.
Pouliquen, P., et al.. (1992). [Exfoliative syndrome and cataract surgery].. PubMed. 15(3). 171–6. 11 indexed citations
17.
Pouliquen, P.. (1972). [The problem of penalisation].. PubMed. 161(2). 130–9. 9 indexed citations
18.
Pouliquen, P.. (1964). [OPTICAL OVERCORRECTION AND THE STRABISMIC ANGLE].. PubMed. 64. 742–5. 3 indexed citations
19.
Pouliquen, P.. (1959). [The beginning of therapy of amblyopia].. PubMed. 1. 82–5. 1 indexed citations
20.
Pouliquen, P.. (1958). [Variations of monocular fixation of the strabismic eye].. PubMed. 1. 69–72. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026